Investor type Venture Capital


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 58
Average round size
The average size of a deal this fund participated in
Portfolio companies 38
Rounds per year 11.60
Lead investments 4
Follow on index
How often the fund supports its portfolio startups at next rounds
Key employees 3
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Software
  • FinTech
  • Financial Services
  • Blockchain
  • Banking

coparion appeared to be the VC, which was created in 2016. The fund was located in Europe if to be more exact in Germany. The main department of described VC is located in the Cologne.

Among the most popular fund investment industries, there are Health Care, FinTech. The fund has no specific favorite in a number of founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Grover, Clark, Wirelane. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Germany.

The typical case for the fund is to invest in rounds with 3-4 participants. Despite the coparion, startups are often financed by Varengold Bank, Senovo, Karl-Heinz Flother. The meaningful sponsors for the fund in investment in the same round are High-Tech Gru00fcnderfonds, Unternehmertum Venture Capital Partners, Earlybird Venture Capital. In the next rounds fund is usually obtained by Earlybird Venture Capital, EASME - EU Executive Agency for SMEs, G1 Venture Capital.

The high activity for fund was in 2018. The common things for fund are deals in the range of 5 - 10 millions dollars. The fund is constantly included in 7-12 deals per year. The real fund results show that this VC is 15 percentage points less often commits exit comparing to other companies.

We also calculated 3 valuable employees in our database.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of coparion:
Typical Co-investors
coparion is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after coparion:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from Germany
Funds with similar focus located in Germany:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Plan A

Social Impact
$10M03 Nov 2021 Berlin, Berlin, Germany


Small and Medium Businesses
$1M28 Oct 2021 Berlin, Berlin, Germany


Event Management
$2M25 Oct 2021 Geneve, Vaud, Switzerland

Abalos Therapeutics

$36M14 Oct 2021 Essen, North Rhine-Westphalia, Germany


Artificial Intelligence
Content Marketing
Direct Sales
Sales Automation
$4M30 Sep 2021 Berlin, Berlin, Germany


Consumer Electronics
Sharing Economy
Subscription Service
$29M28 Jul 2021 Berlin, Berlin, Germany


Financial Services
$10M27 Jun 2021 Berlin, Berlin, Germany


$112M11 May 2021 Munich, Bavaria, Germany


Financial Services
$22M29 Apr 2021 Berlin, Berlin, Germany
Cardior Raises €64M in Series B Funding

– Cardior Pharmaceuticals from Hanover develops non-coding RNA (ncRNA)-based therapeutics for patients with cardiac diseases.
– The company closed a €64m ($76m) Series B financing round.
– The round was led by Inkef Capital, supported by fellow new investors Fund+, Sunstone, Hadean Ventures and Coparion with participation from existing investors including LSP, BioMedPartners, Bristol Myers Squibb and High-Tech Gründerfonds.
– The new investment will be used for the late-stage clinical development of its lead program and the expansion of its earlier-stage pipeline.

Holidu Raises £32M in Series D Funding

– Holidu is a Munich-based technology company in the holiday rental industry.
– The company secured €37m in Series D funding.
– The round was led by 83North with participation from existing investors Prime Ventures, EQT ventures, Coparion, Senovo, Kees Koolen, Lios Ventures and Chris Hitchen. Claret Capital (formerly Harbert European Growth Capital).
– The new investment will be used to further accelerate the company’s growth and expansion of its holiday rental search engine and the expansion of its holiday rental software business with Bookiply.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent coparion?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: